Logo

    hcv

    Explore " hcv" with insightful episodes like "Karen Murray - Hepatitis C", "#49: Our Take May–Part 1", "NEJM Interview: Brigg Reilley on why the Indian Health Service has lagged when it comes to treating patients with hepatitis C.", "The Lancet Global Health: August 28, 2014" and "Response to Global HIV and HCV Epidemic" from podcasts like ""Bowel Sounds: The Pediatric GI Podcast", "Health Care Rounds", "NEJM Interviews", "The Lancet Global Health in conversation with" and "AIDS/HIV: Past, Present, and Future (Audio)"" and more!

    Episodes (26)

    Karen Murray - Hepatitis C

    Karen Murray - Hepatitis C

    In the next episode of Bowel Sounds, hosts Dr. Jenn Lee and Dr. Jason Silverman talk to Dr. Karen Murray, our current NASPGHAN President and Chair of Pediatrics at the Cleveland Clinic.  We talk about hepatitis C, including screening and its evolving treatment.  We also talk about her career, her thoughts on work-life balance, and her advice for young people in the field, particularly young women.  As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.

    Produced by: Jenn Lee and Peter Lu

    Special requests:

    Thank you to everyone for listening to our podcast. If you enjoyed this content and thought it was useful, we would like to ask you to consider doing any or all of 3 things:

    1. Tell one person that you think would like this type of content about the podcast. We want to reach more GI docs and trainees as well as general pediatricians, pediatric residents and med students.
    2. Leave a review on Apple Podcasts - this also helps more people discover our podcast
    3. You can also support the show by making a donation to the NASPGHAN Foundation 


    Support the show

    This episode is eligible for CME credit! Once you have listened to the episode, click this link to claim your credit. Credit is available to NASPGHAN members (if you are not a member, you should probably sign up). And thank you to the NASPGHAN Professional Education Committee for their review!

    As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.

    Check out our merch website!

    Follow us on Twitter, Facebook and Instagram for all the latest news and upcoming episodes.

    Click here to support the show.

    #49: Our Take May–Part 1

    #49: Our Take May–Part 1

    In this week’s episode, John talks EHRs and physician burnout, prescription drug prices in TV ads, and more.

    Highlights include:

    • Gundersen Health System and Marshfield Clinic talk merger.
    • Bon Secours Mercy Health signs letter of intent to acquire Dublin, Ireland-based Bon Secours Health System.
    • UnitedHealthcare’s new bundled payment program for maternity care.
    • U.S. District Court judge struck down the 340B rate cut.
    • Washington becomes the second state to announce a subscription-based payment model for HCV drugs.

    About Darwin Research Group
    Darwin Research Group Inc. provides advanced market intelligence and in-depth customer insights to health care executives, with a strategic focus on health care delivery systems and the global shift toward value-based care. Darwin’s client list includes forward-thinking biopharmaceutical and medical device companies, as well as health care providers, private equity, and venture capital firms. The company was founded in 2010 as Darwin Advisory Partners, LLC and is headquartered in Scottsdale, Ariz. with a satellite office in Princeton, N.J.

    NEJM Interview: Brigg Reilley on why the Indian Health Service has lagged when it comes to treating patients with hepatitis C.

    NEJM Interview: Brigg Reilley on why the Indian Health Service has lagged when it comes to treating patients with hepatitis C.
    Brigg Reilley is HIV/HCV National Programs Epidemiologist at the Northwest Tribal Epidemiology Center at the Northwest Portland Area Indian Health Board. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. B. Reilley and J. Leston. A Tale of Two Epidemics - HCV Treatment among Native Americans and Veterans. N Engl J Med 2017;377:801-3.

    The Lancet Global Health: August 28, 2014

    The Lancet Global Health: August 28, 2014

    Romulus Breban discusses how mathematical modelling can estimate the effect of preventive and treatment interventions for hepatitis C in Egypt.

    Continue this conversation on social!
    Follow us today at...
    https://twitter.com/thelancet
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    Response to Global HIV and HCV Epidemic

    Response to Global HIV and HCV Epidemic
    Three global health experts - Gregg Alton JD, Executive Vice President, Gilead; Ambassador Eric Goosby MD: Global Health Science, UCSF; and Stefano Bertozzi MD PhD, Dean, School of Public Health, UC Berkeley - discuss the role and responsibilities of public and private organizations in the response to the global HIV and HCV epidemics. From policy advances to facilitate access to life saving antiretrovirals for millions of patients, to challenges in regulatory infrastructure, to the rocky path for point-of-care diagnostics and treatment monitoring technologies, to the recognition that treatment is prevention and key to any containment strategy – the lessons provided by the expansion and entrenchment of the HIV epidemic, and successes and failures in the public health response are unparalleled in the global health arena. [Health and Medicine] [Education] [Professional Medical Education] [Show ID: 28103]

    Response to Global HIV and HCV Epidemic

    Response to Global HIV and HCV Epidemic
    Three global health experts - Gregg Alton JD, Executive Vice President, Gilead; Ambassador Eric Goosby MD: Global Health Science, UCSF; and Stefano Bertozzi MD PhD, Dean, School of Public Health, UC Berkeley - discuss the role and responsibilities of public and private organizations in the response to the global HIV and HCV epidemics. From policy advances to facilitate access to life saving antiretrovirals for millions of patients, to challenges in regulatory infrastructure, to the rocky path for point-of-care diagnostics and treatment monitoring technologies, to the recognition that treatment is prevention and key to any containment strategy – the lessons provided by the expansion and entrenchment of the HIV epidemic, and successes and failures in the public health response are unparalleled in the global health arena. [Health and Medicine] [Education] [Professional Medical Education] [Show ID: 28103]
    Logo

    © 2024 Podcastworld. All rights reserved

    Stay up to date

    For any inquiries, please email us at hello@podcastworld.io